Health
High-dose glucocorticoids and IL-6 receptor inhibition reduce COVID-19-associated cytokine storm mortality. – Brinkwire
The Annals of the Rheumatic Diseases, the journal of the European League Against Rheumatism, EULAR, has published findings of an observational study on the treatment of patients with COVID-19-associated Cytokine storm syndrome (CSS). The study demonstrates that a treatment strategy combining intensive immunosuppression (using glucocorticoids and an IL-6 inhibitor) as well as close monitoring dramatically improves patient outcomes when compared to supportive care only.
The study shows that this …
-
Business23 hours agoWhat it means for shareholders
-
Noosa News23 hours agoCalls for greater education as growers in WA’s south-west brace for polyphagous shot-hole borer
-
Noosa News14 hours agoNRL legend Trevor Gillmeister charged with assaulting police officer at Brisbane pub
-
General22 hours agoKim Kardashian not deterred by bar failure